IPO Lockup Expiration: Press Ganey Holdings

Press Ganey Holdings (NYSE: PGND) – Sell or Short Recommendation – PT $30.75

November 17, 2015 concludes the 180-day lockup period on Press Ganey Holdings .

When the lockup period ends for PGND, its pre-IPO shareholders, directors and executives will have the chance to sell their 41 million shares. The potential for a sudden increase in stock available in the open market may cause a significant decrease in Press Ganey shares.

The event opens a short opportunity for experienced investors.

We previewed this event on our IPO Insights platform.

Business Summary: Provider of Performance Measurement Services to the Healthcare Industry

Press Ganey Holdings provides performance analytics, patient experience measurement and strategic advisory services to many sectors within the healthcare industry. The company collects and analyzes data regarding patient experience and suggests solutions based on the information from both patients and caregivers. Their data collection methods include gathering insights via phone, survey, mobile phones and other electronic devices. In addition, the company provides solutions that measure physician, nurse and employee engagement and alignment in order to address their experiences during the care giving process as well.

Press Ganey also offers quality and clinical solutions, including its program to gather nursing quality indicators to improve quality indicator scores; patient reported outcome measurements that collect data on the quality of life and functional status of a patient throughout the course of care; and Core Measures, which is software to collect data on core measurements. In addition, Press Ganey offers a variety of customized consulting services, including implementing physician, nurse and leadership rounding programs, overcoming cultural barriers, creating targeted communication programs and evaluating and modifying work flow. The company serves hospitals, medical practices and other healthcare providers directly.